Ticker
ALGSCompany Name
ALIGOS THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Free Cash Flow | Free Cash Flow Yield | Market Capitalization |
---|---|---|---|
6/30/2025 | $ -75.12M | -151.9% | $ 49.46M |
3/31/2025 | $ -79.01M | -282.12% | $ 28.01M |
12/31/2024 | $ -80.87M | -127.06% | $ 63.65M |
9/30/2024 | $ -85.11M | -253.7% | $ 33.55M |
6/30/2024 | $ -85.33M | -238.92% | $ 35.72M |
3/31/2024 | $ -79.44M | -128.73% | $ 61.71M |
12/31/2023 | $ -79.02M | -120.03% | $ 65.83M |
9/30/2023 | $ -73.22M | -130.3% | $ 56.2M |
6/30/2023 | $ -70.01M | -180.85% | $ 38.71M |
3/31/2023 | $ -81.78M | -140.03% | $ 58.4M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
FCF / Market Cap
(=) FCF Yield
FCF Yield for ALIGOS THERAPEUTICS INC is calculated as follows: FCF [ $ 0 ] / Market Cap [ $ 684.22M ]
(=) FCF Yield [ 0% ]
Minimum
Mar 31, 2025
Maximum
Dec 31, 2020
Average
Median
filtered constituents | 3.58K |
---|---|
min | -33.87% |
max | 37.55% |
average | 1.62% |
median | 3.25% |
std | 11.36% |